Cited by 31Pneumocystis jirovecii pneumonia detection and treatmentPneumonia and Respiratory InfectionsParasitic Infections and Diagnostics

Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan.

TAKAHASHI, TAKASHI, ENDO, TOKIOMI, NAKAMURA, TETSUYA, SAKASHITA, HIROYUKI, KIMURA, KYOKO, OHNISHI, KENJI, KITAMURA, YOSHIHIRO, IWAMOTO, AIKICHI·2002·Journal of Medical Microbiology

Abstract

This study examined polymorphisms in the dihydrofolate reductase (DHFR) gene of Pneumocystis carinii isolates from 27 patients with P. carinii pneumonia (PCP) in Japan. Four substitution sites with two synonymous and two non-synonymous changes were found. Two synonymous substitutions at nucleotide positions 540 and 312 were identified in one and 13 patients, respectively. Two amino acid substitutions (Ala67Val, Cysl66Tyr) were found in two different patients. No linkage of amino acid substitutions in DHFR to those in dihydropteroate synthase was observed. The two patients whose isolates showed non-synonymous DHFR mutations were not exposed to DHFR inhibitors before they developed PCP and were treated successfully with co-trimoxazole.

Integrity signals

Registry

Crossref · 10.1099/0022-1317-51-6-510

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two studies have failed to demonstrate an association between the use of TMP-SMX for PCP prophylaxis in HIV-infected persons and the presence of DHFR gene mutations.

    “To date, two studies have failed to demonstrate an association between the use of TMP-SMX for PCP prophylaxis in HIV-infected persons and the presence of DHFR gene mutations (21,36).”
  • In the second study, 16 (59%) of 27 specimens had DHFR gene mutations, 14 had synonymous changes, and 2 had nonsynonymous changes.

    “In the second study, 16 (59%) of 27 specimens (from 27 patients, 19 of whom were HIV-infected) had DHFR gene mutations, 14 had synonymous changes, and 2 had nonsynonymous changes (36).”
  • This study reported that observed nonsynonymous changes in Pneumocystis DHFR were not in the highly conserved regions of the enzyme as are the amino acid substitutions that confer resistance to TMP (or pyrimethamine) in E. coli, Staphylococcus aureus, Streptococcus pneumoniae, and Plasmodium falciparum.

    “In addition, this study aligned the Pneumocystis DHFR sequences with those of E. coli, Staphylococcus aureus, Streptococcus pneumoniae, and Plasmodium falciparum and reported that the observed nonsynonymous changes in Pneumocystis DHFR were not in the highly conserved regions of the enzyme as are the amino acid substitutions that confer resistance to TMP (or pyrimethamine) in these other organisms”
  • Neither of the two patients whose PCP specimen had nonsynonymous DHFR changes had prior exposure to DHFR inhibitors, yet both patients were treated successfully for PCP with TMP-SMX.

    “Neither of the two patients whose PCP specimen had nonsynonymous DHFR changes had prior exposure to DHFR inhibitors, yet both patients were treated successfully for PCP with TMP-SMX.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
TAKAHASHI, T., ENDO, T., NAKAMURA, T., SAKASHITA, H., KIMURA, K., OHNISHI, K., KITAMURA, Y., & IWAMOTO, A.
Affiliations
Tokyo Metropolitan Bokutoh Hospital (JP)
Venue
Journal of Medical Microbiology
Published
2002-06-01
Volume
51
Issue
6
Pages
510-515
ISSN
  • 0022-2615 (ISSN-L)
  • 1473-5644
OpenAlex
W2101386304
Cited by
31
References
18
Citations by year
2022: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 2
FWCI
2.01
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medical Microbiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasitic Infections and Diagnostics
Keywords
dihydrofolate reductase, Pneumocystis carinii pneumonia, synonymous substitutions, amino acid substitutions, dihydropteroate synthase, drug resistance, Japan
MeSH terms
Amino Acid Sequence, Anti-Infective Agents, Base Sequence, Bronchoalveolar Lavage Fluid, Dihydropteroate Synthase, Gene Amplification, Genes, Fungal, Humans, Japan, Molecular Sequence Data, Mutation, Pneumocystis, Pneumonia, Pneumocystis, Polymorphism, Genetic, Tetrahydrofolate Dehydrogenase, Trimethoprim, Sulfamethoxazole Drug Combination, Polymerase Chain Reaction, Sequence Alignment, Immunocompromised Host, Treatment Failure, Sequence Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review